TreeWAS – Variant ID: rs8102380

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.487	0.513	0.000
I26 Pulmonary embolism	0.210	0.790	0.000
I26.0 Pulmonary embolism with mention of acute cor pulmonale	0.143	0.857	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.036	0.964	0.000
M13.99 Arthritis, unspecified (Site unspecified)	0.000	0.971	0.029
I28 Other diseases of pulmonary vessels	0.025	0.975	0.000
I28.0 Arteriovenous fistula of pulmonary vessels	0.019	0.981	0.000
K50.8 Other Crohn's disease	0.000	0.982	0.018
I28.1 Aneurysm of pulmonary artery	0.018	0.982	0.000
I28.9 Disease of pulmonary vessels, unspecified	0.017	0.982	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.983	0.017
I28.8 Other specified diseases of pulmonary vessels	0.015	0.984	0.000
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.000	0.984	0.016
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.985	0.015
J40 Bronchitis, not specified as acute or chronic	0.000	0.986	0.014
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.986	0.014
T45.0 Antiallergic and antiemetic drugs	0.000	0.988	0.012
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.988	0.012
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.988	0.011
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.989	0.011
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.989	0.011
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.989	0.011
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.989	0.011
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.989	0.011
T40.2 Other opioids	0.000	0.989	0.011
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.989	0.011
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.990	0.010
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.990	0.010
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.990	0.010
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.990	0.010
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.990	0.010
T44.0 Anticholinesterase agents	0.000	0.990	0.010
M23.2 Derangement of meniscus due to old tear or injury	0.000	0.990	0.010
T84.1 Mechanical complication of internal fixation device of bones of limb	0.000	0.990	0.010
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.990	0.010
T40.4 Other synthetic narcotics	0.000	0.990	0.010
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.000	0.990	0.010
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.990	0.010
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.991	0.009
T50.8 Diagnostic agents	0.000	0.991	0.009
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.991	0.009
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.991	0.009
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.991	0.009
Z51.0 Radiotherapy session	0.000	0.991	0.009
T40.1 Heroin	0.000	0.991	0.009
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.992	0.008
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.992	0.008
T50.7 Analeptics and opioid receptor antagonists	0.000	0.992	0.008
T50.5 Appetite depressants	0.000	0.992	0.008
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.992	0.008
T50.1 Loop [high-ceiling] diuretics	0.000	0.992	0.008
T50.0 Mineralocorticoids and their antagonists	0.000	0.992	0.008
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.992	0.008
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.992	0.008
T45.8 Other primarily systemic and haematological agents	0.000	0.992	0.008
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.992	0.008
T45.6 Fibrinolysis-affecting drugs	0.000	0.992	0.008
T45.4 Iron and its compounds	0.000	0.992	0.008
T45.3 Enzymes, not elsewhere classified	0.000	0.992	0.008
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.992	0.008
M23.25 Derangement of meniscus due to old tear or injury (Posterior horn of lateral meniscus)	0.000	0.992	0.008
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.992	0.008
T40.8 Lysergide [LSD]	0.000	0.992	0.008
T40.7 Cannabis (derivatives)	0.000	0.992	0.008
T40.0 Opium	0.000	0.992	0.008
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.992	0.008
C92.0 Acute myeloid leukaemia	0.008	0.992	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.992	0.008
T43.2 Other and unspecified antidepressants	0.000	0.992	0.008
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.992	0.008
T43.9 Psychotropic drug, unspecified	0.000	0.992	0.008
T43.6 Psychostimulants with abuse potential	0.000	0.992	0.008
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.992	0.008
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.992	0.007
M23.27 Derangement of meniscus due to old tear or injury-Capsular	0.000	0.992	0.007
M23.21 Derangement of meniscus due to old tear or injury (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.992	0.008
K50.1 Crohn's disease of large intestine	0.000	0.992	0.008
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.992	0.007
K50 Crohn's disease [regional enteritis]	0.000	0.992	0.008
T45.5 Anticoagulants	0.000	0.993	0.007
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.993	0.007
T45.2 Vitamins, not elsewhere classified	0.000	0.993	0.007
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.993	0.007
F05.9 Delirium, unspecified	0.007	0.993	0.000
T40.5 Cocaine	0.000	0.993	0.007
T40.3 Methadone	0.000	0.993	0.007
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.993	0.007
D04.3 Skin of other and unspecified parts of face	0.000	0.993	0.007
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.993	0.007
T40.6 Other and unspecified narcotics	0.000	0.993	0.007
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.993	0.007
T38.9 Other and unspecified hormone antagonists	0.000	0.993	0.007
T38.7 Androgens and anabolic congeners	0.000	0.993	0.007
T38.4 Oral contraceptives	0.000	0.993	0.007
T38.2 Antithyroid drugs	0.000	0.993	0.007
T38.0 Glucocorticoids and synthetic analogues	0.000	0.993	0.007
Z98.8 Other specified postsurgical states	0.000	0.993	0.007
T50.4 Drugs affecting uric acid metabolism	0.000	0.993	0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.993	0.007
T38.5 Other oestrogens and progestogens	0.000	0.993	0.006
T38.1 Thyroid hormones and substitutes	0.000	0.994	0.006
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.994	0.006
T48.5 Anti-common-cold drugs	0.000	0.994	0.006
T41.5 Therapeutic gases	0.000	0.994	0.006
T41.4 Anaesthetic, unspecified	0.000	0.994	0.006
T41.3 Local anaesthetics	0.000	0.994	0.006
T41.2 Other and unspecified general anaesthetics	0.000	0.994	0.006
T41.1 Intravenous anaesthetics	0.000	0.994	0.006
T41.0 Inhaled anaesthetics	0.000	0.994	0.006
H10.9 Conjunctivitis, unspecified	0.000	0.994	0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.994	0.006
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.994	0.006
T48.4 Expectorants	0.000	0.994	0.006
T48.3 Antitussives	0.000	0.994	0.006
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.994	0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.994	0.006
T48.0 Oxytocic drugs	0.000	0.994	0.006
C25.0 Head of pancreas	0.006	0.994	0.000
G44.2 Tension-type headache	0.006	0.994	0.000
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.994	0.006
C92.1 Chronic myeloid leukaemia	0.006	0.994	0.000
T36 Poisoning by systemic antibiotics	0.000	0.994	0.006
C92 Myeloid leukaemia	0.006	0.994	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.994	0.006
T37.5 Antiviral drugs	0.000	0.994	0.006
T37.4 Anthelminthics	0.000	0.994	0.006
T37.3 Other antiprotozoal drugs	0.000	0.994	0.006
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.994	0.006
T37.1 Antimycobacterial drugs	0.000	0.994	0.006
T37.0 Sulphonamides	0.000	0.994	0.006
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.994	0.006
D04.5 Skin of trunk	0.000	0.994	0.006
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.006	0.994	0.000
C25.9 Pancreas, unspecified	0.006	0.994	0.000
T49.9 Topical agent, unspecified	0.000	0.994	0.005
T49.8 Other topical agents	0.000	0.994	0.005
T49.7 Dental drugs, topically applied	0.000	0.994	0.005
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.994	0.005
T49.5 Ophthalmological drugs and preparations	0.000	0.994	0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.994	0.005
T49.3 Emollients, demulcents and protectants	0.000	0.994	0.005
T49.2 Local astringents and local detergents	0.000	0.994	0.005
T49.1 Antipruritics	0.000	0.994	0.005
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.994	0.006
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.994	0.005
I25.1 Atherosclerotic heart disease	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.995	0.005
T42.3 Barbiturates	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
C25 Malignant neoplasm of pancreas	0.005	0.995	0.000
D04 Carcinoma in situ of skin	0.000	0.995	0.005
M19.99 Arthrosis, unspecified (Site unspecified)	0.000	0.995	0.005
F29 Unspecified nonorganic psychosis	0.000	0.995	0.005
I27 Other pulmonary heart diseases	0.005	0.995	0.000
C92.7 Other myeloid leukaemia	0.005	0.995	0.000
T39.0 Salicylates	0.000	0.995	0.005
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.995	0.005
T42.2 Succinimides and oxazolidinediones	0.000	0.995	0.005
D04.9 Skin, unspecified	0.000	0.995	0.005
C92.2 Subacute myeloid leukaemia	0.005	0.995	0.000
K50.0 Crohn's disease of small intestine	0.000	0.995	0.005
T39.4 Antirheumatics, not elsewhere classified	0.000	0.995	0.005
T39.2 Pyrazolone derivatives	0.000	0.995	0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.004
F05 Delirium, not induced by alcohol and other psychoactive substances	0.005	0.995	0.000
T47.0 Histamine H(2)-receptor antagonists	0.000	0.995	0.004
M48.02 Spinal stenosis (Cervical region)	0.000	0.995	0.005
R57.2 Septic shock	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.995	0.004
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.995	0.004
T47.7 Emetics	0.000	0.995	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.995	0.004
T47.5 Digestants	0.000	0.995	0.004
T47.3 Saline and osmotic laxatives	0.000	0.995	0.004
C92.5 Acute myelomonocytic leukaemia	0.005	0.995	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.995	0.005
T36.9 Systemic antibiotic, unspecified	0.000	0.995	0.004
T36.7 Antifungal antibiotics, systemically used	0.000	0.995	0.004
T36.6 Rifamycins	0.000	0.995	0.004
T36.5 Aminoglycosides	0.000	0.995	0.004
T36.2 Chloramphenicol group	0.000	0.995	0.004
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.004	0.995	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.004	0.995	0.000
C92.3 Myeloid sarcoma	0.004	0.995	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.000	0.995	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.995	0.004
T42.4 Benzodiazepines	0.000	0.995	0.005
M19.97 Arthrosis, unspecified (Ankle and foot)	0.000	0.995	0.005
T47.4 Other laxatives	0.000	0.995	0.004
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.000	0.995	0.005
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.004
T36.4 Tetracyclines	0.000	0.995	0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
C25.3 Pancreatic duct	0.004	0.996	0.000
C25.4 Endocrine pancreas	0.004	0.996	0.000
C92.4 Acute promyelocytic leukaemia	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T42.1 Iminostilbenes	0.000	0.996	0.004
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
C25.7 Other parts of pancreas	0.004	0.996	0.000
T36.3 Macrolides	0.000	0.996	0.004
C25.2 Tail of pancreas	0.004	0.996	0.000
H18.6 Keratoconus	0.004	0.996	0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.000	0.996	0.004
C25.8 Overlapping lesion of pancreas	0.004	0.996	0.000
D04.4 Skin of scalp and neck	0.000	0.996	0.004
G24.9 Dystonia, unspecified	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T36.0 Penicillins	0.000	0.996	0.004
T46.1 Calcium-channel blockers	0.000	0.996	0.004
D04.8 Skin of other sites	0.000	0.996	0.004
D04.0 Skin of lip	0.000	0.996	0.004
M19.92 Arthrosis, unspecified (Upper arm)	0.000	0.996	0.004
C92.9 Myeloid leukaemia, unspecified	0.004	0.996	0.000
D04.1 Skin of eyelid, including canthus	0.000	0.996	0.004
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.000	0.996	0.004
D04.7 Skin of lower limb, including hip	0.000	0.996	0.004
M19.0 Primary arthrosis of other joints	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
F05.0 Delirium not superimposed on dementia, so described	0.004	0.996	0.000
T36.8 Other systemic antibiotics	0.000	0.996	0.004
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.996	0.004
I27.1 Kyphoscoliotic heart disease	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.004
C25.1 Body of pancreas	0.004	0.996	0.000
D04.2 Skin of ear and external auricular canal	0.000	0.996	0.004
M19.9 Arthrosis, unspecified	0.000	0.996	0.004
F05.1 Delirium superimposed on dementia	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.000	0.996	0.004
H34.8 Other retinal vascular occlusions	0.000	0.996	0.004
I27.8 Other specified pulmonary heart diseases	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
Z91.5 Personal history of self-harm	0.000	0.996	0.004
I34.1 Mitral (valve) prolapse	0.000	0.996	0.004
M19 Other arthrosis	0.000	0.996	0.004
T39.1 4-Aminophenol derivatives	0.000	0.996	0.004
M19.93 Arthrosis, unspecified (Forearm)	0.000	0.996	0.004
F05.8 Other delirium	0.003	0.996	0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.000	0.996	0.003
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.996	0.004
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.000	0.996	0.003
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.000	0.996	0.003
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
M19.08 Primary arthrosis of other joints (Other)	0.000	0.997	0.003
M19.1 Posttraumatic arthrosis of other joints	0.000	0.997	0.003
X62.9 Unspecified place	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.001	0.997	0.003
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.000	0.997	0.003
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.003	0.997	0.000
N81.6 Rectocele	0.003	0.997	0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
H18 Other disorders of cornea	0.003	0.997	0.000
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.997	0.003
H18.2 Other corneal oedema	0.003	0.997	0.000
N80.0 Endometriosis of uterus	0.000	0.997	0.003
M19.8 Other specified arthrosis	0.000	0.997	0.003
Y44.2 Anticoagulants	0.003	0.997	0.000
Z54.0 Convalescence following surgery	0.000	0.997	0.003
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.997	0.003
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.997	0.003
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.997	0.003
M19.2 Other secondary arthrosis	0.000	0.997	0.003
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.997	0.003
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.997	0.003
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.997	0.003
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.000	0.997	0.003
M19.90 Arthrosis, unspecified (Multiple sites)	0.000	0.997	0.003
H18.9 Disorder of cornea, unspecified	0.003	0.997	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.000	0.997	0.003
M19.18 Post-traumatic arthrosis of other joints (Other)	0.000	0.997	0.003
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.000	0.997	0.003
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.000	0.997	0.003
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.000	0.997	0.003
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.000	0.997	0.003
H02.4 Ptosis of eyelid	0.000	0.997	0.003
H18.1 Bullous keratopathy	0.003	0.997	0.000
G24 Dystonia	0.000	0.997	0.003
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.000	0.997	0.003
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
M19.89 Other specified arthrosis (Site unspecified)	0.000	0.997	0.003
H18.0 Corneal pigmentations and deposits	0.003	0.997	0.000
M54.4 Lumbago with sciatica	0.000	0.997	0.003
Z95.5 Presence of coronary angioplasty implant and graft	0.003	0.997	0.000
H18.5 Hereditary corneal dystrophies	0.003	0.997	0.000
H34.1 Central retinal artery occlusion	0.000	0.997	0.003
M19.87 Other specified arthrosis (Ankle and foot)	0.000	0.997	0.002
M19.23 Other secondary arthrosis (Forearm)	0.000	0.997	0.002
H18.3 Changes in corneal membranes	0.002	0.997	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.002	0.997	0.000
H18.7 Other corneal deformities	0.002	0.997	0.000
G24.3 Spasmodic torticollis	0.000	0.997	0.002
H35.3 Degeneration of macula and posterior pole	0.003	0.997	0.000
M19.86 Other specified arthrosis (Lower leg)	0.000	0.997	0.002
M19.85 Other specified arthrosis (Pelvic region and thigh)	0.000	0.997	0.002
M19.83 Other specified arthrosis (Forearm)	0.000	0.997	0.002
M19.82 Other specified arthrosis (Upper arm)	0.000	0.997	0.002
M19.80 Other specified arthrosis (Multiple sites)	0.000	0.997	0.002
I27.9 Pulmonary heart disease, unspecified	0.002	0.997	0.000
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.000	0.998	0.002
M19.84 Other specified arthrosis (Hand)	0.000	0.998	0.002
M19.88 Other specified arthrosis (Other)	0.000	0.998	0.002
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.000	0.998	0.002
R50.8 Other specified fever	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
H34 Retinal vascular occlusions	0.000	0.998	0.002
H18.8 Other specified disorders of cornea	0.002	0.998	0.000
M19.81 Other specified arthrosis (Shoulder region)	0.000	0.998	0.002
M19.21 Other secondary arthrosis (Shoulder region)	0.000	0.998	0.002
M24.01 Loose body in joint (Shoulder region)	0.000	0.998	0.002
M19.29 Other secondary arthrosis (Site unspecified)	0.000	0.998	0.002
M19.28 Other secondary arthrosis (Other)	0.000	0.998	0.002
M19.26 Other secondary arthrosis of other joints-Lower leg	0.000	0.998	0.002
M19.25 Other secondary arthrosis (Pelvic region and thigh)	0.000	0.998	0.002
M19.24 Other secondary arthrosis (Hand)	0.000	0.998	0.002
M19.22 Other secondary arthrosis (Upper arm)	0.000	0.998	0.002
M19.20 Other secondary arthrosis (Multiple sites)	0.000	0.998	0.002
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.998	0.002
G24.5 Blepharospasm	0.000	0.998	0.002
H18.4 Corneal degeneration	0.002	0.998	0.000
H43.3 Other vitreous opacities	0.000	0.998	0.002
G24.8 Other dystonia	0.000	0.998	0.002
X62.8 Other specified place	0.000	0.998	0.002
X67.9 Unspecified place	0.000	0.998	0.002
M13.96 Arthritis, unspecified (Lower leg)	0.000	0.998	0.002
H34.9 Retinal vascular occlusion, unspecified	0.000	0.998	0.002
X62.0 Home	0.000	0.998	0.002
X62.7 Farm	0.000	0.998	0.002
X62.6 Industrial and construction area	0.000	0.998	0.002
X62.5 Trade and service area	0.000	0.998	0.002
X62.4 Street and highway	0.000	0.998	0.002
X62.3 Sports and athletics area	0.000	0.998	0.002
X62.2 School, other institution and public administrative area	0.000	0.998	0.002
X62.1 Residential institution	0.000	0.998	0.002
F00-F09 Organic, including symptomatic, mental disorders	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.000	0.998	0.002
G24.1 Idiopathic familial dystonia	0.000	0.998	0.002
M24.07 Loose body in joint (Ankle and foot)	0.000	0.998	0.002
G24.4 Idiopathic orofacial dystonia	0.000	0.998	0.002
G24.2 Idiopathic nonfamilial dystonia	0.000	0.998	0.002
O34.1 Maternal care for tumour of corpus uteri	0.002	0.998	0.000
F00 Dementia in Alzheimer's disease	0.002	0.998	0.000
M24.0 Loose body in joint	0.000	0.998	0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
N80.1 Endometriosis of ovary	0.000	0.998	0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.000	0.998	0.002
F02.3 Dementia in Parkinson's disease	0.002	0.998	0.000
G24.0 Drug-induced dystonia	0.000	0.998	0.002
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.000	0.998	0.002
M24.04 Loose body in joint (Hand)	0.000	0.998	0.002
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.998	0.002
M54.44 Lumbago with sciatica-Thoracic	0.000	0.998	0.002
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.998	0.002
M54.42 Lumbago with sciatica-Cervical	0.000	0.998	0.002
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.998	0.002
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.998	0.002
S82.30 Fracture of lower end of tibia (closed)	0.002	0.998	0.000
D04.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
X60.8 Other specified place	0.000	0.998	0.002
X63.0 Home	0.000	0.998	0.002
F02 Dementia in other diseases classified elsewhere	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
X60.2 School, other institution and public administrative area	0.000	0.998	0.002
X65 Intentional self-poisoning by and exposure to alcohol	0.000	0.998	0.002
G44 Other headache syndromes	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.002	0.998	0.000
X61.4 Street and highway	0.000	0.998	0.002
M19.27 Other secondary arthrosis (Ankle and foot)	0.000	0.998	0.002
G44.4 Drug-induced headache, not elsewhere classified	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
D37.4 Colon	0.002	0.998	0.000
H34.0 Transient retinal artery occlusion	0.000	0.998	0.002
N80.3 Endometriosis of pelvic peritoneum	0.000	0.998	0.002
Z94.7 Corneal transplant status	0.002	0.998	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.998	0.002
X65.8 Other specified place	0.000	0.998	0.002
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
F00.1 Dementia in Alzheimer's disease with late onset	0.002	0.998	0.000
N80.5 Endometriosis of intestine	0.000	0.998	0.002
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.000	0.998	0.002
F60 Specific personality disorders	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.000	0.998	0.002
G44.3 Chronic posttraumatic headache	0.002	0.998	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.000	0.998	0.002
Z36.0 Antenatal screening for chromosomal anomalies	0.002	0.998	0.000
M24.06 Loose body in joint-Lower leg	0.000	0.998	0.002
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.000	0.998	0.002
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.000	0.998	0.002
X81 Intentional self-harm by jumping or lying before moving object	0.000	0.998	0.002
X80 Intentional self-harm by jumping from a high place	0.000	0.998	0.002
X79 Intentional self-harm by blunt object	0.000	0.998	0.002
X77 Intentional self-harm by steam, hot vapours and hot objects	0.000	0.998	0.002
X76 Intentional self-harm by smoke, fire and flames	0.000	0.998	0.002
X75 Intentional self-harm by explosive material	0.000	0.998	0.002
X74 Intentional self-harm by other and unspecified firearm discharge	0.000	0.998	0.002
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.000	0.998	0.002
X72 Intentional self-harm by handgun discharge	0.000	0.998	0.002
X71 Intentional self-harm by drowning and submersion	0.000	0.998	0.002
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.000	0.998	0.002
M24.05 Loose body in joint (Pelvic region and thigh)	0.000	0.998	0.002
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
X60.9 Unspecified place	0.000	0.998	0.002
X60.0 Home	0.000	0.998	0.002
X60.7 Farm	0.000	0.998	0.002
X60.6 Industrial and construction area	0.000	0.998	0.002
X60.4 Street and highway	0.000	0.998	0.002
X60.3 Sports and athletics area	0.000	0.998	0.002
X60.1 Residential institution	0.000	0.998	0.002
M24.09 Loose body in joint (Site unspecified)	0.000	0.998	0.002
M24.08 Loose body in joint (Other)	0.000	0.998	0.002
M24.00 Loose body in joint (Multiple sites)	0.000	0.998	0.002
C71.3 Parietal lobe	0.000	0.998	0.002
Q21.0 Ventricular septal defect	0.000	0.998	0.002
T51.9 Alcohol, unspecified	0.000	0.998	0.002
X69.9 Unspecified place	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.000	0.998	0.002
M24.02 Loose body in joint (Upper arm)	0.000	0.998	0.002
C71.9 Brain, unspecified	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.000	0.998	0.002
X61.2 School, other institution and public administrative area	0.000	0.998	0.002
X63.9 Unspecified place	0.000	0.998	0.002
X63.8 Other specified place	0.000	0.998	0.002
X63.7 Farm	0.000	0.998	0.002
X63.6 Industrial and construction area	0.000	0.998	0.002
X63.5 Trade and service area	0.000	0.998	0.002
X63.4 Street and highway	0.000	0.998	0.002
X63.3 Sports and athletics area	0.000	0.998	0.002
X63.2 School, other institution and public administrative area	0.000	0.998	0.002
X63.1 Residential institution	0.000	0.998	0.002
X67.8 Other specified place	0.000	0.998	0.002
X67.7 Farm	0.000	0.998	0.002
X67.6 Industrial and construction area	0.000	0.998	0.002
X67.5 Trade and service area	0.000	0.998	0.002
X67.4 Street and highway	0.000	0.998	0.002
X67.3 Sports and athletics area	0.000	0.998	0.002
X67.2 School, other institution and public administrative area	0.000	0.998	0.002
X67.1 Residential institution	0.000	0.998	0.002
F09 Unspecified organic or symptomatic mental disorder	0.002	0.998	0.000
H10 Conjunctivitis	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.002	0.998	0.000
U81.0 Vancomycin resistant agent	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.000	0.998	0.002
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
F02.2 Dementia in Huntington's disease	0.002	0.998	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.002	0.998	0.000
X61.9 Unspecified place	0.000	0.998	0.002
X61.8 Other specified place	0.000	0.998	0.002
X61.0 Home	0.000	0.998	0.002
X61.7 Farm	0.000	0.998	0.002
X61.6 Industrial and construction area	0.000	0.998	0.002
X61.5 Trade and service area	0.000	0.998	0.002
X61.3 Sports and athletics area	0.000	0.998	0.002
X61.1 Residential institution	0.000	0.998	0.002
X84 Intentional self-harm by unspecified means	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.000	0.998	0.002
M18.1 Other primary arthrosis of first carpometacarpal joint	0.000	0.998	0.002
M48.09 Spinal stenosis (Site unspecified)	0.000	0.998	0.002
I21.0 Acute transmural myocardial infarction of anterior wall	0.002	0.998	0.000
N39.9 Disorder of urinary system, unspecified	0.002	0.998	0.000
X65.9 Unspecified place	0.000	0.998	0.002
X65.0 Home	0.000	0.998	0.002
X65.7 Farm	0.000	0.998	0.002
X65.6 Industrial and construction area	0.000	0.998	0.002
X65.5 Trade and service area	0.000	0.998	0.002
X65.4 Street and highway	0.000	0.998	0.002
X65.3 Sports and athletics area	0.000	0.998	0.002
X65.2 School, other institution and public administrative area	0.000	0.998	0.002
X65.1 Residential institution	0.000	0.998	0.002
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
F02.0 Dementia in Pick's disease	0.002	0.998	0.000
G93.4 Encephalopathy, unspecified	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.000	0.998	0.002
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.000	0.998	0.002
X68 Intentional self-poisoning by and exposure to pesticides	0.000	0.998	0.002
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.002	0.998	0.000
F03 Unspecified dementia	0.002	0.998	0.000
N80 Endometriosis	0.000	0.998	0.002
M19.94 Arthrosis, unspecified (Hand)	0.000	0.998	0.002
C71.4 Occipital lobe	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations